The negative impact of cytomegalovirus (CMV) infection on transplant outcomes warrants
efforts toward improving its prevention, diagnosis, and treatment. During the last 2 decades …

Cytomegalovirus (CMV), the fifth member of the human herpesvirus family, is one of the
largest viruses known to cause clinical disease. It is a double‐stranded DNA virus that …

Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …

We compared the efficacy and safety of valganciclovir with those of oral ganciclovir in
preventing cytomegalovirus (CMV) disease in high-risk seronegative solid organ transplant …

Importance Despite the use of a cytomegalovirus (CMV) prevention strategy of antiviral
prophylaxis for high-risk CMV-seronegative liver transplant recipients with seropositive …

Background: Cytomegalovirus (CMV), the most common opportunistic viral infection in solid
organ transplant recipients, is associated with substantial morbidity and mortality. Purpose …

Despite remarkable advances in the diagnostic and therapeutic modalities for its
management, cytomegalovirus (CMV) remains one of the most important pathogens …

The Canadian Society of Transplantation sponsored a Cytomegalovirus (CMV) Consensus
Working Group that met on March 19, 2003. The objectives of this group were to determine …

Cytomegalovirus (CMV) infections were first described in the early years of the twentieth
century when the typical owl's eye intranuclear inclusions were found by histopathologists in …

Human cytomegalovirus (HCMV) infections are common and lead to lifelong infections. In
immunocompetent individuals, primary infections are mostly subclinical or they may be …